Geoff McGrane

Geoff McGrane has over a decade of experience in the business development and investment sectors of the life sciences industry. Geoff is currently the AVP of Business Development at the New York Stem Cell Foundation. Prior to this, they were the Senior Director of Business Development at the New York Stem Cell Foundation Research Institute from January 2021 to July 2022. Geoff has also held positions as the Director of Business Development at the New York Stem Cell Foundation Research Institute from October 2018 to December 2020, VP Development at 58 Diagnostics from January 2018 to October 2018, and Business Development Manager at Smartzyme Biopharma from September 2016 to April 2018. In addition to their business development experience, Geoff McGrane also has experience as an investor. Geoff was a Principal at MedPro Investors from March 2015 to December 2019 and a Senior Analyst at S&P Capital IQ LCD from January 2010 to August 2014.

Geoff McGrane has an MBA from Columbia University - Columbia Business School, a BA in Economics from New York University, and certification from Coursera in Science of Stem Cells (AMNH), Design and Interpretation of Clinical Trials (Johns Hopkins), edX in Biology (MIT), Physiology (Duke), and Biology of Cancer (Johns Hopkins).

They are on a team with Dwayne Cadogan - Senior Director, IT, Christine M. Lin - Chief Advancement Officer, and Lisa Voltolina - Associate Director, Clinical Research & Regulatory Compliance. Geoff McGrane reports to Susan L. Solomon, CEO & Founder. A direct report to Geoff McGrane is and Krystal Voltaire - Business Development Coordinator.